Korsana Biosciences

Korsana Biosciences was founded to reduce the burden of neurodegenerative diseases for patients and caregivers. 

MA combine
Biotech

Alzheimer's-focused Korsana uses Cyclerion merger to go public

After emerging from stealth with $175 million in funding, Korsana Biosciences has entered into a reverse merger with Cyclerion Therapeutics.
Will Maddox Apr 1, 2026 9:54am